# Pilot Study of Ustekinumab for Subjects With Chronic Atopic Dermatitis

> **NCT01806662** · PHASE2 · COMPLETED · sponsor: **Rockefeller University** · enrollment: 32 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** Ustekinumab
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01806662
- **Lead sponsor:** Rockefeller University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2018-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01806662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01806662, "Pilot Study of Ustekinumab for Subjects With Chronic Atopic Dermatitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01806662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*